Evidence-Based Medicine
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2014; 20(44): 16702-16706
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16702
Figure 4
Figure 4 Expressions of Gastrokine 1 mRNA in diffuse type and intestinal type gastric cancer. cP < 0.01 vs superficial gastritis group; dP < 0.01 vs diffuse type gastric cancer.